Main > ONCOLOGY (**) > Leukemia>Lymphocytic>Chronic>R/R>** > TREAT.: > CN. B. BTK Inhibitor Capsules



CN. B. BTK Inhibitor Capsules's subsections
(*) EU CE Mark Date: 2022. 11.17
(*) UK Approval Date: 2023. 01.19
Company
EP Patent Number
Generic Name
RTM
RTM Web-Site

CN. B. BTK Inhibitor Capsules's products
This section has no products